Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective
Clinical Pharmacokinetics · 2025-09 · 64 (9) · 1283-1293
DOI: 10.1007/s40262-025-01558-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 12.08.2025. Verfasst von Nokwanda N Ngcobo. Beteiligte Einrichtung: Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa. ngcobon11@ukzn.ac.za. Hauptthemen laut MEDLINE: Malnutrition, Pharmacokinetics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of KwaZulu-Natal.
Themen: Mangelernährung
Abstract (Originalsprache)
Malnutrition significantly alters the pharmacokinetics of medications, particularly in vulnerable populations such as children, pregnant women, elderly individuals, and individuals in low- and middle-income countries. These populations are often more vulnerable to the effects of malnutrition because of physiological, metabolic and socioeconomic factors. Changes in body composition, organ function and plasma protein levels associated with malnutrition can impact drug absorption, distribution, metabolism and excretion. In malnourished individuals, decreased serum albumin levels may increase the free (unbound) fraction of highly protein-bound acidic drugs, potentially elevating the risk of toxicity. However, this relationship is not universally straightforward, as it depends on the drug's protein-binding characteristics, hepatic and renal function, volume of distribution and compensatory changes in drug clearance. In addition, malnutrition's effects on liver enzymes, such as cytochrome P450 isoforms, and kidney function can result in unpredictable drug clearance, particularly for narrow-therapeutic-index medications. Emerging evidence also highlights the interplay between malnutrition and pharmacogenomics, with genetic variations further modulating drug metabolism and response. Addressing these complexities requires the development of tailored dosing regimens and adaptive therapeutic strategies to optimise treatment outcomes in these at-risk groups. This review accentuates the critical need for more robust research to inform clinical guidelines and improve health equity in managing malnourished populations globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa. ngcobon11@ukzn.ac.za.
ORCID-Profile: Nokwanda N Ngcobo
Förderung
- University of KwaZulu-Natal
Zitieren
APA
Ngcobo, N. N. (2025). Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective. Clinical Pharmacokinetics, 64(9), 1283-1293. https://doi.org/10.1007/s40262-025-01558-5
Vancouver
Ngcobo NN. Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective. Clinical Pharmacokinetics. 2025;64(9):1283-1293. doi:10.1007/s40262-025-01558-5
BibTeX
@article{Ngcobo2025,
author = {Ngcobo, Nokwanda N},
title = {Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective},
journal = {Clinical Pharmacokinetics},
year = {2025},
volume = {64},
number = {9},
pages = {1283--1293},
doi = {10.1007/s40262-025-01558-5}
}
EUVIMED